About Temozolomide
            
            Class: | Antineoplastic agent, Alkylating agent  
Use: | Treatment of glioblastoma multiforme and anaplastic astrocytoma; used as a part of a treatment regimen for certain types of brain tumors  
Adult dose: | Initial dose of 75 mg/m²/day for 42 days, followed by a dose of 150-200 mg/m² on days 1-5 of each 28-day cycle  
Pediatric dose: | Not established; use in pediatric patients should be based on clinical judgment and specific circumstances  
Side effects: | Nausea, vomiting, fatigue, headach
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Alkylating agent
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of glioblastoma multiforme and anaplastic astrocytoma; used as a part of a treatment regimen for certain types of brain tumors
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: HIKMA PHARMACEUTICALS CO.LTD, JORDAN
                    
                    
                    Package Size
                    5s
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 697.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 75 mg/m²/day for 42 days, followed by a dose of 150-200 mg/m² on days 1-5 of each 28-day cycle
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; use in pediatric patients should be based on clinical judgment and specific circumstances
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, fatigue, headache, constipation, dizziness, and myelosuppression (including thrombocytopenia and leukopenia)
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to temozolomide or any component of the formulation; pregnancy (Category D)
         
        
        
            
                Important Warnings
            
            Risk of myelosuppression; monitor complete blood counts; potential for secondary malignancies; use with caution in patients with liver impairment; avoid in pregnant or breastfeeding women
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.